Analysis of Antibacterial, Antioxidant, and In Vitro Methane Mitigation Activities of Fermented Scutellaria baicalensis Georgi Extract*

Marbun, Tabita Dameria; Song, Jaeyong; Lee, Kihwan; Kim, Su Yeon; Kang, Ju-Hui; Lee, Sang Moo; Choi, Young Min; Cho, Sangbuem; Bae, Gui-Seck; Chang, M. B.; Kim, Eun Joong

doi:10.11625/kjoa.2016.24.4.735

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The approach describing a composition comprising a bacteriocin and an extract from a plant is described in a patent of Coyne et al (Coyne et al 2014). This kind of strategy has been gaining strength and evidencing in numerous cases where the interruption of bacterial growth appears to be ineffective due to the use of these vegetable broths in conjunction with specific microbiotas (Marbun et al 2016). Besides, extracts of tea and soybean showed dose-dependent growth inhibition of pathogens (Zhao & Shah 2015).…”

Section: Bacteriocins As a Biotechnology Tool In The Treatment By S mentioning

confidence: 99%

Bacteriocins as an alternative in the treatment of infections by Staphylococcus aureus

Leite¹,

Oliveira²,

Carmo

et al. 2020

An. Acad. Bras. Ciênc.

View full text Add to dashboard Cite

Staphylococcus aureus (S. aureus) is a highly versatile Gram-positive bacterium that is carried asymptomatically by up to 30% of healthy people, while being a major cause of healthcare-associated infections, making it a worldwide problem in clinical medicine. The adaptive evolution of S. aureus strains is demonstrated by its remarkable capacity to promptly develop high resistance to multiple antibiotics, thus limiting treatment choice. Nowadays, there is a continuous demand for an alternative to the use of antibiotics for S. aureus infections and a strategy to control the spread or to kill phylogenetically related strains. In this scenario, bacteriocins fi t as with a promising and interesting alternative. These molecules are produced by a range of bacteria, defi ned as ribosomally synthesized peptides with bacteriostatic or bactericidal activity against a wide range of pathogens. This work reviews ascertained the main antibiotic-resistance mechanisms of S. aureus strains and the current, informative content concerning the applicability of the use of bacteriocins overlapping the use of conventional antibiotics in the context of S. aureus infections. Besides, we highlight the possible application of these biomolecules on an industrial scale in future work.

show abstract

Section: Bacteriocins As a Biotechnology Tool In The Treatment By S mentioning

confidence: 99%

Bacteriocins as an alternative in the treatment of infections by Staphylococcus aureus

Leite¹,

Oliveira²,

Carmo

et al. 2020

An. Acad. Bras. Ciênc.

View full text Add to dashboard Cite

show abstract

Analysis of Antibacterial, Antioxidant, and In Vitro Methane Mitigation Activities of Fermented Scutellaria baicalensis Georgi Extract*

Cited by 1 publication

References 0 publications

Bacteriocins as an alternative in the treatment of infections by Staphylococcus aureus

Bacteriocins as an alternative in the treatment of infections by Staphylococcus aureus

Contact Info

Product

Resources

About